Exact Mass: 308.9975
Exact Mass Matches: 308.9975
Found 115 metabolites which its exact mass value is equals to given mass value 308.9975,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Lamivudine-monophosphate
Lamivudine-monophosphate is a metabolite of lamivudine. Lamivudine (2,3-dideoxy-3-thiacytidine, commonly called 3TC) is a potent nucleoside analog reverse transcriptase inhibitor (nRTI). It is marketed by GlaxoSmithKline with the brand names Zeffix, Heptovir, Epivir, and Epivir-HBV. Lamivudine has been used for treatment of chronic hepatitis B at a lower dose than for treatment of HIV. It improves the seroconversion of e-antigen positive hepatitis B and also improves histology staging of the liver. (Wikipedia)
2,8-bis-Trifluoromethyl-4-quinoline carboxylic acid
2,8-bis-Trifluoromethyl-4-quinoline carboxylic acid is a metabolite of mefloquine. Mefloquine hydrochloride (also known as Lariam or Mefaquin) is an orally administered medication used in the prevention and treatment of malaria. Mefloquine was developed in the 1970s at the United States Department of Defenses Walter Reed Army Institute of Research as a synthetic analogue of quinine. The brand name drug, Lariam, is manufactured by the Swiss company Hoffmann–La Roche. In August 2009, Roche stopped marketing Lariam in the United States. (Wikipedia)
3-oxobrimonidine
3-oxobrimonidine is a metabolite of brimonidine. Brimonidine (bri-MOE-ni-deen, brand names Alphagan and Alphagan-P) is a drug used to treat open-angle glaucoma or ocular hypertension. It acts via decreasing synthesis of aqueous humor, and increasing the amount that drains from the eye through uveoscleral outflow. As a treatment for glaucoma, it is usually given in eyedrop form. (Wikipedia)
2,8-BIS(TRIFLUROMETHYL)-4-QUINOLINCARBOXYLIC ACID
2-(2-Benzenesulfonamido-5-pyrimidinyloxy)acetic acid
ethyl 6-bromo-8-methyl-4-oxo-1H-quinoline-3-carboxylate
5-(CHLOROMETHYL)-2-(2-FLUORO-4-(TRIFLUOROMETHYL)PHENYL)-4-METHYLTHIAZOLE
3-Chloro-4-[1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy]benzenamine
METHYL 3-([3-(CHLOROMETHYL)BENZOYL]AMINO)THIOPHENE-2-CARBOXYLATE
TERT-BUTYL 3-BROMO-7-METHYL-1H-INDOLE-1-CARBOXYLATE
Ethyl1-(5-bromopyridin-2-yl)-5-methylpyrazole-4-carboxylate
5-Bromo-1-(4-methoxybenzyl)-1H-pyrrole-2-carboxylic acid
2,5-Cyclohexadien-1-one,4-[[4-(acetyloxy)phenyl]imino]-2,6-dichloro-
Ethanone,2-chloro-1-(2-chloro-10H-phenothiazin-10-yl)-
3-(3-chlorophenyl)-4-cyano-5-methylsulfanylthiophene-2-carboxylic acid
3-(4-CHLOROPHENYL)-4-CYANO-5-(METHYLTHIO)THIOPHENE-2-CARBOXYLIC ACID
ETHYL5-AMINO-1-(4-BROMOPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE
METHYL 2-([3-(CHLOROMETHYL)BENZOYL]AMINO)THIOPHENE-3-CARBOXYLATE
METHYL 3-AMINO-4-(ISOPROPYLSULFONYL)-5-(METHYLTHIO)THIOPHENE- 2-CARBOXYLATE
[2-(3-bromo-phenyl)-ethyl]-(4-chloro-phenyl)-amine
6-Chloro-4-hydroxy-2-methyl-2H-thieno[2,3-e]-1,2-thiazine-3-carboxylic acid methyl ester 1,1-dioxide
ETHYL 5-AMINO-1-(2-BROMOPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE
TERT-BUTYL 5-(BROMOMETHYL)-1H-INDOLE-1-CARBOXYLATE
2-[2-(2-amino-1,3-thiazol-4-yl)ethyl]isoindole-1,3-dione,hydrochloride
5-chloro-N-(2,4-difluorophenyl)thiophene-2-sulfonamide
tert-butyl 4-(bromomethyl)-1H-indole-1-carboxylate
2-[2-(1-bromonaphthalen-2-yl)oxyethylamino]ethanol
3-Chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-ol 5,5-dioxide
4-ISOXAZOLECARBOXYLIC ACID, 5-(4-BROMOPHENYL)-3-METHYL-, ETHYL ESTER
TERT-BUTYL 7-(BROMOMETHYL)-1H-INDOLE-1-CARBOXYLATE
Ethyl 3-bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate hydrochloride
2-(4-chloro-2-methylphenoxy)-N-(2-chlorophenyl)acetamide
5-bromo-N-cyclopentyl-2-(trifluoromethyl)pyrimidin-4-amine
5-bromo-n-(2-hydroxyethyl)-2-methoxybenzenesulfonamide
4-[(4-CHLOROPHENYL)SULFANYL]-3-NITROBENZENECARBOXYLIC ACID
4-ISOXAZOLECARBOXYLIC ACID, 3-(4-BROMOPHENYL)-5-METHYL-, ETHYL ESTER
Brofaromine
D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor
Anagrelide hydrochloride monohydrate
C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent
5-Hydroxydiclofenac quinone imine
A quinone imine that is a metabolite of diclofenac arising from 5-hydroxylation followed by oxidation.
6-Amino-5-[(4-chlorophenyl)sulfonyl]-2-hydroxynicotinonitrile
1-Methyl-3-trifluoromethyl-1H-thieno[2,3-C]pyrazole-5-carboxylic acid (2-mercapto-ethyl)-amide
N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]formamide
(2R)-2-amino-3-(6-chloro-2-phenylpyrimidin-4-yl)sulfanylpropanoic acid
N-[(E)-(5-bromothiophen-2-yl)methylideneamino]pyridine-2-carboxamide
(2Z)-2-[(3,4-dioxocyclohexa-1,5-dien-1-yl)methylidene]-4-(4-hydroxyphenyl)-5-oxo-2,5-dihydrofuran-3-olate
4-hydroxydiclofenac quinone imine
A quinone imine that is a metabolite of diclofenac arising from 4-hydroxylation followed by oxidation.
